160 related articles for article (PubMed ID: 26119099)
1. Copper(II) complexation of tacrine hybrids with potential anti-neurodegenerative roles.
Quintanova C; Keri RS; Chaves S; Santos MA
J Inorg Biochem; 2015 Oct; 151():58-66. PubMed ID: 26119099
[TBL] [Abstract][Full Text] [Related]
2. Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.
Hamulakova S; Poprac P; Jomova K; Brezova V; Lauro P; Drostinova L; Jun D; Sepsova V; Hrabinova M; Soukup O; Kristian P; Gazova Z; Bednarikova Z; Kuca K; Valko M
J Inorg Biochem; 2016 Aug; 161():52-62. PubMed ID: 27230386
[TBL] [Abstract][Full Text] [Related]
3. Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer's agents: AChE inhibition, antioxidant activity and metal chelating capacity.
Chand K; Alsoghier HM; Chaves S; Santos MA
J Inorg Biochem; 2016 Oct; 163():266-277. PubMed ID: 27235273
[TBL] [Abstract][Full Text] [Related]
4. New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease.
Keri RS; Quintanova C; Chaves S; Silva DF; Cardoso SM; Santos MA
Chem Biol Drug Des; 2016 Jan; 87(1):101-11. PubMed ID: 26256122
[TBL] [Abstract][Full Text] [Related]
5. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
6. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
[TBL] [Abstract][Full Text] [Related]
7. Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.
Bolognesi ML; Cavalli A; Valgimigli L; Bartolini M; Rosini M; Andrisano V; Recanatini M; Melchiorre C
J Med Chem; 2007 Dec; 50(26):6446-9. PubMed ID: 18047264
[TBL] [Abstract][Full Text] [Related]
8. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.
Costa M; Josselin R; Silva DF; Cardoso SM; May NV; Chaves S; Santos MA
J Inorg Biochem; 2020 May; 206():111039. PubMed ID: 32171933
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
11. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
12. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.
Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
15. Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease.
Fancellu G; Chand K; Tomás D; Orlandini E; Piemontese L; Silva DF; Cardoso SM; Chaves S; Santos MA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):211-226. PubMed ID: 31760822
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
17. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug.
Chand K; Rajeshwari ; Candeias E; Cardoso SM; Chaves S; Santos MA
Metallomics; 2018 Oct; 10(10):1460-1475. PubMed ID: 30183790
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property.
Liu Z; Fang L; Zhang H; Gou S; Chen L
Bioorg Med Chem; 2017 Apr; 25(8):2387-2398. PubMed ID: 28302511
[TBL] [Abstract][Full Text] [Related]
19. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
[TBL] [Abstract][Full Text] [Related]
20. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
